Wird geladen...
Pharmacogenomics in early-phase clinical development
Pharmacogenomics (PGx) offers the promise of utilizing genetic fingerprints to predict individual responses to drugs in terms of safety, efficacy and pharmacokinetics. Early-phase clinical trial PGx applications can identify human genome variations that are meaningful to study design, selection of p...
Gespeichert in:
| Veröffentlicht in: | Pharmacogenomics |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4551460/ https://ncbi.nlm.nih.gov/pubmed/23837482 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs.13.81 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|